Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
about
Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy.A role for tau in learning, memory and synaptic plasticity.Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficits.Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy.AAV2-mediated GRP78 Transfer Alleviates Retinal Neuronal Injury by Downregulating ER Stress and Tau Oligomer Formation
P2860
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
@en
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
@nl
type
label
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
@en
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
@nl
prefLabel
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
@en
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
@nl
P2093
P2860
P1476
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.
@en
P2093
Julia E Gerson
Rakez Kayed
Urmi Sengupta
P2860
P304
P356
10.1007/978-1-4939-6598-4_9
P407
P577
2017-01-01T00:00:00Z